Endeavor

New KRAS-Targeted Drugs Show Early Signals in Advanced Lung Cancer

Investigational therapies show tumor shrinkage in patients after standard treatments stop working

Community Events Aim To Spread Lung Cancer Awareness

Moffitt’s mobile lung screening program is hosting an educational cooking class and lung health trivia

Is Proton Therapy Better for Head and Neck Cancer Patients?

Study shows proton radiation increases survival outcomes in patients with HPV-related cancers

When Tumor Structure Shapes Immune Response

Study finds collagen remodeling can trap and suppress cancer-fighting T cells, helping explain why some patients don’t respond to immunotherapy

Mobile Screening Units Aim To Increase Access to Cancer Screening

Moffitt launched its mobile lung cancer screening unit in November of 2024

Turning the Immune System Back On: A New Approach to Treating Breast Cancer

Blocking a specific enzyme may unlock the immune system’s potential to attack tumors

Why Do Cancer Immunotherapy Side Effects Differ Among Patients?

Moffitt researchers find genetics may help predict severe colon inflammation in melanoma care

New Oral Targeted Therapy Shows Benefit in Hard to Treat Cancers

Early phase trial results show signs of tumor response and disease control in patients with advanced melanoma, colon, ovarian, cervical and thymic cancers

New Research Offers Hope for KRAS-Driven Lung Cancer

Study explores how blocking cancer’s survival pathway may improve responses in KRAS-mutant lung cancer